Genotype plays role in schizophrenia response to folate
From Clinical Psychiatry News, 19 March 2013: Folate and vitamin B12 supplements may improve the negative symptoms of schizophrenia but only in patients with a genetic variant that influences folate metabolism, a study has shown. “Although four such variants have previously been associated with negative symptom severity, the genotype that contributed most strongly to treatment … Continue reading Genotype plays role in schizophrenia response to folate